{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:07:31Z","timestamp":1780549651433,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":13,"publisher":"Springer US","isbn-type":[{"value":"9781071618875","type":"print"},{"value":"9781071618882","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1888-2_16","type":"book-chapter","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T18:03:25Z","timestamp":1637690605000},"page":"269-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccines Against Vector-Borne Diseases"],"prefix":"10.1007","author":[{"given":"Chrysoula","family":"Kitsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"16_CR1","unstructured":"WHO (2016) Vector-borne diseases. http:\/\/wwwwhoint\/mediacentre\/factsheets\/fs387\/en\/"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1086\/319347","volume":"32","author":"P Parola","year":"2001","unstructured":"Parola P, Raoult D (2001) Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 32:897\u2013928. https:\/\/doi.org\/10.1086\/319347","journal-title":"Clin Infect Dis"},{"key":"16_CR3","first-page":"467","volume-title":"Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Caister","author":"RT Marconi","year":"2010","unstructured":"Marconi RT, Earnhart CG (2010) Lyme disease vaccines. In: Samuels DS, Radolf JD (eds) Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Caister. Academic Press, Norfolk, UK, pp 467\u2013486"},{"issue":"48","key":"16_CR4","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.1016\/j.vaccine.2011.09.035","volume":"29","author":"M Kumar","year":"2011","unstructured":"Kumar M, Kaur S, Kariu T, Yang X, Bossis I, Anderson JF, Pal U (2011) Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine. Vaccine 29(48):9012\u20139019. https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.035","journal-title":"Vaccine"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/infdis\/jiw013","volume":"213","author":"F Kung","year":"2016","unstructured":"Kung F, Kaur S, Smith AA, Yang X, Wilder CN, Sharma K, Buyuktanir O, Pal U (2016) A Borrelia burgdorferi surface-exposed transmembrane protein lacking detectable immune responses supports pathogen persistence and constitutes a vaccine target. J Infect Dis 213:1786\u20131795. https:\/\/doi.org\/10.1093\/infdis\/jiw013","journal-title":"J Infect Dis"},{"issue":"6","key":"16_CR6","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/infdis\/jix036","volume":"215","author":"P Singh","year":"2016","unstructured":"Singh P, Verma D, Backstedt BT, Kaur S, Kumar M, Smith AA, Sharma K, Yang X, Azevedo JF, Gomes-Solecki M, Buyuktanir O, Pal U (2016) Borrelia burgdorferi BBI39 paralogs are targets of protective immunity inducing microbicidal responses and reducing pathogen persistence either in hosts or in the vector. J Infect Dis 215(6):1000\u20131009. https:\/\/doi.org\/10.1093\/infdis\/jix036","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"16_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11259-007-0069-5","volume":"31","author":"J de la Fuente","year":"2007","unstructured":"de la Fuente J, Kocan KM, Blouin EF (2007) Tick vaccines and the transmission of tick-borne pathogens. Vet Res Commun 31(Suppl 1):85\u201390","journal-title":"Vet Res Commun"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-3389-1_17","volume":"1404","author":"A Rodriguez-Mallon","year":"2016","unstructured":"Rodriguez-Mallon A (2016) Developing anti-tick vaccines. Methods Mol Biol 1404:243\u2013259. https:\/\/doi.org\/10.1007\/978-1-4939-3389-1_17","journal-title":"Methods Mol Biol"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/14760584.2016.1111142","volume":"15","author":"R Smit","year":"2016","unstructured":"Smit R, Postma MJ (2016) Vaccines for tick-borne diseases and cost-effectiveness of vaccination: a public health challenge to reduce the diseases\u2019 burden. Expert Rev Vaccines 15:5\u20137. https:\/\/doi.org\/10.1586\/14760584.2016.1111142","journal-title":"Expert Rev Vaccines"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1756-3305-7-77","volume":"7","author":"H Sprong","year":"2014","unstructured":"Sprong H, Trentelman J, Seemann I, Grubhoffer L, Rego RO, Hajdusek O, Kopacek P, Sima R, Nijhof AM, Anguita J, Winter P, Rotter B, Havlikova S, Klempa B, Schetters TP, Hovius JW (2014) ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe. Parasit Vectors 7:77. https:\/\/doi.org\/10.1186\/1756-3305-7-77","journal-title":"Parasit Vectors"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1050-3862(99)00018-2","volume":"15","author":"J de la Fuente","year":"1999","unstructured":"de la Fuente J, Rodriguez M, Montero C, Redondo M, Garcia-Garcia JC, Mendez L, Serrano E, Valdes M, Enriquez A, Canales M, Ramos E, Boue O, Machado H, Lleonart R (1999) Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac (in eng). Genet Anal 15:143\u2013148","journal-title":"Genet Anal"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.vaccine.2006.09.085","volume":"25","author":"D Odongo","year":"2007","unstructured":"Odongo D, Kamau L, Skilton R, Mwaura S, Nitsch C, Musoke A, Taracha E, Daubenberger C, Bishop R (2007) Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus (in eng). Vaccine 25:1287\u20131296. https:\/\/doi.org\/10.1016\/j.vaccine.2006.09.085","journal-title":"Vaccine"},{"issue":"Suppl","key":"16_CR13","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1017\/S0031182003004657","volume":"129","author":"P Willadsen","year":"2004","unstructured":"Willadsen P (2004) Anti-tick vaccines. Parasitology 129(Suppl):S367\u2013S387","journal-title":"Parasitology"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1888-2_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T18:12:28Z","timestamp":1637691148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1888-2_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"ISBN":["9781071618875","9781071618882"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1888-2_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"24 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}